Professor Jennifer Martin takes on the RACP presidency at a time of unprecedented upheaval for the college.
Her predecessor, Dr Jacqueline Small, resigned less than two months ago, citing concerns over governance, as did the college’s recently-appointed CEO, Lee Whitney.
Adding to the sense of turbulence, the RACP is preparing to undertake a major investment in overhauling its curriculum and technology that will see it plunge into the red for at least the next four years.
Meanwhile, there are new challenges on the horizon, including a battle for reaccreditation with the Australian Medical Council and competition for members in the form of the new CPD Homes.
A clinical pharmacologist and senior academic at the University of Newcastle, Professor Martin spoke with the limbic shortly after the RACP Congress in Sydney.
The limbic: When you were elected two years ago, you spoke about your priorities being things like health reform and climate change. Will issues like these need to go on the backburner while you sort out the internal mess you’ve inherited at the RACP?
Professor Martin: It can be hard to put on a positive face externally if you haven’t got your own house in order, so that’s a fair question. We do need to get our internal systems working and the college performing at its best internally for members.
But there is still a very important external agenda, with the Federal Budget handed down a few days ago being an important example. It has impacts on health and climate, as you have just alluded to, and our members expect us to be out there talking about those issues and supporting policy that is conducive to good health out there.
Nevertheless, I am very focused on getting some of these internal concerns addressed, particularly in our big education and training portfolio. It is really important to us because we are an education body and we can’t afford to fail again on that.
The good news is we’ve just had a review from our external regulator that supported the significant changes we’re putting in place to improve our performance in education and training. We’re going to keep focusing on that and our other internal issues, but it won’t be at the expense of our quite powerful external advocacy.
Your immediate predecessor, Dr Jacqueline Small, raised concerns about college governance in her resignation announcement earlier this year, as did the former CEO. Do you think there is a governance crisis? And, if so, what needs to be done to fix it?
Professor Martin: ‘Governance’ is a fairly vague word. It can mean a lot of different things to different people. But it’s not something you really hear about when organisations are sound. Board chairs don’t usually need to publicly discuss their governance.
However, for the record we have been working with external governance experts intermittently for a long period of time, constantly aiming for best board practices. In 2019, when the Australian Charities and Not-for-profits Commission – our regulator – came into the college, they did cite poor board governance and gave the college a number of recommendations and things to address. Since April, when I became chair and now president, we have been really working on addressing those issues.
Governance is an evolving process though and there are always new governance challenges. It will be the job of the board to address those and get the culture right at the top and to lead from the top.
Has a new permanent CEO been appointed?
We have an interim CEO and he has agreed to stay until we get a permanent CEO in place. He is very, very experienced and understood the issues that we needed to get across very quickly and the board are delighted to be working with him.
As a board, we have a very good relationship with the interim CEO and we’re enabling him to run the operations of the college under the oversight of the board and in line with our board strategy and the operational plan. We have also been continuing our work with external governance experts and have seen important changes from that, particularly around the importance of empowering the CEO to deliver the business.
Is the multimillion dollar technology investment announced at the time of Mr Whitney and Dr Small’s resignations still going ahead? Why is it so expensive?